Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Nishiguchi

Showing results (141-150 of 303) with videos related to

Pageof 31
Sort By:
Medicine|September 8, 2016
A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validationHiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 20, 2003
Effects of alanine in patients with advanced primary biliary cirrhosis: preliminary reportShuhei Nishiguchi, Daiki Habu, Shoji Kubo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 18, 2003
Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assaysMadoka Kohmoto, Masaru Enomoto, Yoshihisa Yano, et al.
Journal of Medical Virology|January 10, 2002
GB virus C and TT virus infections in Japanese patients with autoimmune hepatitisShuhei Nishiguchi, Masaru Enomoto, Susumu Shiomi, et al.
Hepato-Gastroenterology|December 13, 2005
Ultrasonographic diagnosis of degree of chronic type C liver diseaseDaiki Habu, Shuhei Nishiguchi, Masaru Enomoto, et al.
Scientific Reports|September 24, 2017
The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesisHirayuki Enomoto, Lihua Tao, Ryoji Eguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 16, 2007
Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virusShoji Kubo, Hiromu Tanaka, Shigekazu Takemura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2007
Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseasesAkihiro Tamori, Mayumi Shinzaki, Saori Kosaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2006
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosisYasutoshi Muto, Shunichi Sato, Akiharu Watanabe, et al.
Oncology Reports|November 14, 2013
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinomaHiroki Nishikawa, Yukio Osaki, Ryuichi Kita, et al.
Pageof 31

Showing results (141-150 of 303) with videos related to

Sort By:
Pageof 31
Medicine|September 8, 2016
A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validationHiroki Nishikawa, Norihiro Nishijima, Hirayuki Enomoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 20, 2003
Effects of alanine in patients with advanced primary biliary cirrhosis: preliminary reportShuhei Nishiguchi, Daiki Habu, Shoji Kubo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 18, 2003
Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assaysMadoka Kohmoto, Masaru Enomoto, Yoshihisa Yano, et al.
Journal of Medical Virology|January 10, 2002
GB virus C and TT virus infections in Japanese patients with autoimmune hepatitisShuhei Nishiguchi, Masaru Enomoto, Susumu Shiomi, et al.
Hepato-Gastroenterology|December 13, 2005
Ultrasonographic diagnosis of degree of chronic type C liver diseaseDaiki Habu, Shuhei Nishiguchi, Masaru Enomoto, et al.
Scientific Reports|September 24, 2017
The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesisHirayuki Enomoto, Lihua Tao, Ryoji Eguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 16, 2007
Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virusShoji Kubo, Hiromu Tanaka, Shigekazu Takemura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2007
Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseasesAkihiro Tamori, Mayumi Shinzaki, Saori Kosaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2006
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosisYasutoshi Muto, Shunichi Sato, Akiharu Watanabe, et al.
Oncology Reports|November 14, 2013
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinomaHiroki Nishikawa, Yukio Osaki, Ryuichi Kita, et al.
Pageof 31